Tafazzin Antibody | 46-466

Tafazzin Antibody | 46-466 | Gentaur UK, US & Europe Distribution

Host: Goat

Reactivity: Human

Homology: Expected Species Reactivity based on sequence homology: Mouse, Rat, Dog

Immunogen: The immunogen for this antibody is: C-HLKTQAEQLHNH

Research Area: Cancer

Tested Application: E, WB

Application: Peptide ELISA: antibody detection limit dilution 1:32000.Western Blot:Approx 28kDa band observed in Human Heart lysates (calculated MW of 33.5kDa according to NP_000107.1, 30.2kDa according to NP_851828.1, 31.7kDa according to NP_851829.1 and 28.5 according to NP_851830.1) . Recommended concentration: 0.3-1.0 ug/ml.

Specificiy: This antibody is expected to recognise isoforms 1to 4 (NP_000107.1; NP_851828.1; NP_851829.1; NP_851830.1, respectively) .

Positive Control 1: Cat. No. 1301 - Human Heart Tissue Lysate

Positive Control 2: N/A

Positive Control 3: N/A

Positive Control 4: N/A

Positive Control 5: N/A

Positive Control 6: N/A

Molecular Weight: N/A

Validation: N/A

Isoform: N/A

Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Clonality: Polyclonal

Clone: N/A

Isotype: N/A

Conjugate: Unconjugated

Physical State: Liquid

Buffer: Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. Aliquot and store at -20°C. Minimize freezing and thawing.

Concentration: 500 ug/mL

Storage Condition: Aliquot and store at -20˚C. Minimize freezing and thawing.

Alternate Name: TAZ, tafazzin (cardiomyopathy, dilated 3A (X-linked) endocardial fibroelastosis 2 Barth syndrome) , HGNC:11577, BTHS, CMD3A, EFE, EFE2, G4.5, XAP-2, OTTHUMP00000061673, cardiomyopathy, dilated 3A (X-linked) , tafazzin, XX-FW83563B9.3, FLJ27390, Taz1, LVNCX

User Note: N/A

BACKGROUND: N/A